title: Genetic susceptibility to triple-negative breast cancer.
abstract: Triple-negative breast cancers (TNBC), defined by the absence of estrogen receptor, progesterone receptor, and HER-2 expression, account for 12% to 24% of all breast cancers. TNBC is associated with early recurrence of disease and poor outcome. Germline mutations in the BRCA1 and BRCA2 breast cancer susceptibility genes have been associated with up to 15% of TNBC, and TNBC accounts for 70% of breast tumors arising in BRCA1 mutation carriers and 16% to 23% of breast tumors in BRCA2 carriers. Whether germline mutations in other breast cancer susceptibility genes also predispose to TNBC remains to be determined. Common variation in a subset of the 72 known breast cancer susceptibility loci identified through genome-wide association studies and other large-scale genotyping efforts have also been associated with risk of TNBC (TOX3, ESR1, RAD51L1, TERT, 19p13.1, 20q11, MDM4, 2p24.1, and FTO). Furthermore, variation in the 19p13.1 locus and the MDM4 locus has been associated with TNBC, but not other forms of breast cancer, suggesting that these are TNBC-specific loci. Thus, TNBC can be distinguished from other breast cancer subtypes by a unique pattern of common and rare germline predisposition alleles. Additional efforts to combine genetic and epidemiologic data are needed to better understand the etiology of this aggressive form of breast cancer, to identify prevention and therapeutic targets, and to impact clinical practice through the development of risk prediction models.
authors.affiliation: Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: Kristen N
authors.initials: KN
authors.lastname: Stevens
authors.forename: Celine M
authors.initials: CM
authors.lastname: Vachon
authors.forename: Fergus J
authors.initials: FJ
authors.lastname: Couch
mesh_terms: D001943:Breast Neoplasms / Q000209:etiology* / Q000378:metabolism; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*; D012307:Risk Factors
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
references.citation: Nat Genet. 2013 Apr;45(4):392-8, 398e1-2
references.pmid: 23535733
references.citation: Nat Genet. 2010 Oct;42(10):885-92
references.pmid: 20852631
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23
references.pmid: 12829800
references.citation: Breast Cancer Res Treat. 2008 May;109(1):123-39
references.pmid: 17578664
references.citation: Nat Genet. 2013 Apr;45(4):371-84, 384e1-2
references.pmid: 23535731
references.citation: Cancer Res. 2012 Apr 1;72(7):1795-803
references.pmid: 22331459
references.citation: Nat Genet. 2008 Jun;40(6):703-6
references.pmid: 18438407
references.citation: Nature. 2007 Jun 28;447(7148):1087-93
references.pmid: 17529967
references.citation: Hum Mol Genet. 2012 Dec 15;21(24):5373-84
references.pmid: 22976474
references.citation: Breast Cancer Res Treat. 2011 Aug;129(1):185-90
references.pmid: 21394499
references.citation: Genes Dev. 2009 Mar 15;23(6):719-28
references.pmid: 19261748
references.citation: Ann Oncol. 2011 Jan;22 Suppl 1:i11-7
references.pmid: 21285145
references.citation: Nat Genet. 2013 Apr;45(4):353-61, 361e1-2
references.pmid: 23535729
references.citation: Hum Mol Genet. 2011 Aug 15;20(16):3289-303
references.pmid: 21596841
references.citation: N Engl J Med. 2010 Mar 18;362(11):986-93
references.pmid: 20237344
references.citation: Cancer. 2007 May 1;109(9):1721-8
references.pmid: 17387718
references.citation: Nature. 2012 Oct 4;490(7418):61-70
references.pmid: 23000897
references.citation: Breast Cancer Res. 2012 Feb 20;14(1):R33
references.pmid: 22348646
references.citation: Breast Cancer Res. 2010;12(5):R68
references.pmid: 20813035
references.citation: Hum Mol Genet. 2011 Aug 15;20(16):3304-21
references.pmid: 21593217
references.citation: PLoS Genet. 2010 Jul 22;6(7):e1001029
references.pmid: 20661439
references.citation: Nat Genet. 2007 Mar;39(3):352-8
references.pmid: 17293864
references.citation: J Clin Oncol. 2012 May 20;30(15):1879-87
references.pmid: 22454417
references.citation: Int J Biochem Cell Biol. 2010 Jul;42(7):1080-3
references.pmid: 20417304
references.citation: Nat Genet. 2007 Jul;39(7):870-4
references.pmid: 17529973
references.citation: J Natl Cancer Inst. 2011 Mar 2;103(5):425-35
references.pmid: 21263130
references.citation: N Engl J Med. 2010 Nov 11;363(20):1938-48
references.pmid: 21067385
references.citation: Nat Genet. 2009 May;41(5):579-84
references.pmid: 19330030
references.citation: Nat Genet. 2009 Mar;41(3):324-8
references.pmid: 19219042
references.citation: Nat Genet. 2011 Oct 30;43(12):1210-4
references.pmid: 22037553
references.citation: Nat Genet. 2009 May;41(5):585-90
references.pmid: 19330027
references.citation: Cancer Res. 2010 Dec 1;70(23):9742-54
references.pmid: 21118973
references.citation: Nat Genet. 2007 Jul;39(7):865-9
references.pmid: 17529974
references.citation: Gene. 2012 May 1;498(2):135-46
references.pmid: 22381618
references.citation: Breast Cancer Res Treat. 2009 May;115(1):185-92
references.pmid: 18523885
references.citation: Cancer Res. 2011 Oct 1;71(19):6240-9
references.pmid: 21844186
references.citation: Mutat Res. 2012 Feb 1;730(1-2):28-36
references.pmid: 21575645
references.citation: Front Biosci (Landmark Ed). 2010 Jun 01;15:1105-18
references.pmid: 20515744
references.citation: Hum Mol Genet. 2011 Dec 1;20(23):4693-706
references.pmid: 21852249
references.citation: Nat Genet. 2012 Jan 22;44(3):312-8
references.pmid: 22267197
references.citation: Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47
references.pmid: 22144499
references.citation: J Clin Oncol. 2008 Sep 10;26(26):4282-8
references.pmid: 18779615
references.citation: Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12629-33
references.pmid: 20616022
references.citation: Br J Cancer. 2012 Mar 13;106(6):1234-8
references.pmid: 22333603
references.citation: Breast Cancer Res Treat. 2009 Nov;118(1):131-7
references.pmid: 19189211
references.citation: J Clin Invest. 2011 Jul;121(7):2750-67
references.pmid: 21633166
references.citation: Nature. 2012 Apr 18;486(7403):346-52
references.pmid: 22522925
references.citation: Nat Genet. 2010 Jun;42(6):504-7
references.pmid: 20453838